{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:31:21Z","timestamp":1791919881811,"version":"4.3.4"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s50773","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T21:40:00Z","timestamp":1410471600000},"page":"1335","source":"Crossref","is-referenced-by-count":285,"title":["Update on developments with SGLT2 inhibitors in the management of type 2 diabetes"],"prefix":"10.2147","author":[{"given":"Michael","family":"Nauck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,9]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=21571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:36:57Z","timestamp":1477852617000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/update-on-developments-with-sglt2-inhibitors-in-the-management-of-type-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s50773","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}